Happy “Liberation Day,” Everyone!
After much anticipation, President Trump is set to hold a “Make America Wealthy Again” event at 4:00 PM EST today in the Rose Garden, where he’ll unveil his tariff plans.
Investors are understandably on edge. Although the Nasdaq and S&P 500 saw a slight uptick yesterday, stock futures are trending downward as of now.
With everyone making their moves, don’t expect the market to settle in any clear direction today, as major investors hedge their bets on both sides of the market before the announcement.
Our prediction? Trump will likely avoid the “worst-case” scenario, and stocks could rally in relief as a result.
FOCUS LIST🔎
IBG – Up over 200% in the pre-market on no news
SPWH – Up over 35% in pre after reporting better than expected earnings
GLSI – Up over 22% in pre after announcing positive immune response data from FLAMINGO-01 Phase III clinical trial
*sponsored by RYSE
The Smart Home disruptor with 200% growth…
No, it’s not Ring or Nest—meet RYSE, the company redefining smart shade automation, and you can invest before its next major growth phase.
With $10M+ in revenue and distribution in 127 Best Buy locations, RYSE is rapidly emerging as a top acquisition target in the booming smart home industry, projected to grow 23% annually.
Its patented retrofit technology allows users to automate their window shades in minutes, controlled via smartphone or voice. With 200% year-over-year growth, demand is skyrocketing.
Now, RYSE’s public offering is live at just $1.90/share.
Past performance is not indicative of future results. Email may contain forward-looking statements. See US Offering for details. Informational purposes only.
HOTLIST🔥
IBG – Up over 200% in the pre-market on no news
Innovation Beverage Group (IBG) together with its subsidiaries, develops, manufactures, sells, and exports alcoholic beverages in Australia and the United States.
Despite no discernible news release, short term traders have flocked to IBG overnight with stock trading up over 200% in the pre-market this morning.
The first target for bulls is the pre-market high at $1.83. Beyond that, $2, $2.30, $3 and $3.35 come into play.
Below $1.83, targets to the downside are $1.42, $1.20, $1, $0.80 and then a gap fill at $0.4982.
SPWH – Up over 35% in pre after reporting better than expected earnings
Sportsman’s Warehouse Holdings Inc. (SPWH) together with its subsidiaries, operates as an outdoor sporting goods retailer in the United States.
In the after-hours yesterday, the company announced financial results for the thirteen and fifty-two weeks ended February 1, 2025.
Highlights include:
Q4 same store sales of -0.5% on comparable 13-week basis, versus -12.8% in Q4 last year
Q4 Adj EBITDA of $14.6 million versus $5.3 million in Q4 last year; reduced net debt by $27.3 million versus end of last year
Inventory decreased $12.8 million versus end of last year; ended FY2024 with liquidity of $131.1 million
Significantly outperformed the Q4 adjusted NICS data
Expects positive same store sales in 2025
Shares of SPWH traded up over 35% in the pre-market in reaction to the news.
The first target for bulls is the pre-market $1.60. Beyond that, $1.85, $1.95, $2.05 and $2.20 come into play.
Below $1.60, targets to the downside are $1.40, $1.30, $1.22, $1.10 and then a gap fill at $0.9650.
GLSI – Up over 22% in pre after announcing positive immune response data from FLAMINGO-01 Phase III clinical trial
Greenwich LifeSciences Inc. (GLSI) is a clinical-stage biopharmaceutical company that develops novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers.
Overnight, the company announced positive immune response data from FLAMINGO-01 Phase III clinical trial.
Highlights include:
The number of patients experiencing an immune response increased over time from baseline through the 4th to 6th month vaccinations in both HLA-A*02 and non-HLA-A*02 arms.
In addition, a baseline immune response to GP2 is being observed before any treatment with GP2 in both HLA-A*02 and non-HLA-A*02 arms. This result suggests that GP2 is a natural antigen, that may have been part of an immune response in the patient during prior trastuzumab or other treatments.
Shares of GLSI traded up over 22% in the pre-market in reaction to the positive results.
The first target for bulls is the pre-market high at $11.97, Beyond that, $13, $13.33, $14, $14.41 and $15 come into play.
Below $11.97, targets to the downside are $11, $10.50, $9.50 and a gap fill at $9.26.
MARKET NEWS 📰
Don’t miss out on our MOBILE ALERTS! Some of these alerts have rocketed 🚀past the MOON 🌝. Text “RAGE” to 1-(888) 487-1534📲.
*Disclosure: By texting “Alerts” to 1-(888) 487-1534, you agree to receive promotional messages sent via an autodialer. You also agree to the terms of service and privacy policy. This agreement isn’t a condition of any purchase. Message frequency varies. Message and data rates may apply. Reply STOP to opt out; HELP for more information.
DISCLAIMER: To more fully understand any Ragingbull.com, LLC (“RagingBull”) subscription, website, application or other service (“Services”), please review our full disclaimer located at https://ragingbull.com/disclaimer
FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. Any RagingBull Service offered is for educational and informational purposes only and should NOT be construed as a securities-related offer or solicitation, or be relied upon as personalized investment advice. RagingBull strongly recommends you consult a licensed or registered professional before making any investment decision.
RESULTS PRESENTED NOT TYPICAL OR VERIFIED. RagingBull Services may contain information regarding the historical trading performance of RagingBull owners or employees, and/or testimonials of non-employees depicting profitability that are believed to be true based on the representations of the persons voluntarily providing the testimonial. However, subscribers’ trading results have NOT been tracked or verified and past performance is not necessarily indicative of future results, and the results presented in this communication are NOT TYPICAL. Actual results will vary widely given a variety of factors such as experience, skill, risk mitigation practices, market dynamics and the amount of capital deployed. Investing in securities is speculative and carries a high degree of risk; you may lose some, all, or possibly more than your original investment.
RAGINGBULL IS NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. Neither RagingBull nor any of its owners or employees is registered as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization. Employees, owners, and other service providers of https:// ragingbull. com or RagingBull.com LLC are paid in whole or in part by commission based on their sales of Services to subscribers.
RagingBull.com, LLC shall be entitled to recover attorneys’ fees, costs and disbursements. In the event that any suit or action is instituted as a result of doing business with RagingBull. com, LLC and/or its affiliates or if any suit or action is necessary to enforce or interpret these Terms of Service, RagingBull. com, LLC shall be entitled to recover attorneys’ fees, costs and disbursements in addition to any other relief to which it may be entitled.
*Sponsored content: RYSE has previously paid RagingBull.com (RB) thirty thousand dollars in cash and thirty thousand in shares to run advertisements enhancing public awareness of the company. RB is currently invested in this company. RB is currently an affiliate for RYSE. RB is not responsible for any content hosted on affiliate’s sites and it is the affiliate’s responsibility to ensure compliance with applicable laws. We recommend that you do your own independent research before purchasing anything. While we believe in the companies we form affiliate relationships with, please don’t spend any money on these products unless you believe they will help you achieve your goals.
WE MAY HOLD SECURITIES DISCUSSED. RagingBull has not been paid directly or indirectly by the issuer of any security mentioned in the Services except possibly by advertisers in this email. However, Ragingbull.com, LLC, its owners, and its employees may purchase, sell, or hold long or short positions in securities of the companies mentioned in this communication.
